10-Q Filing

LIFECORE BIOMEDICAL, INC. DE CIK: 1005286 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001437749-16-023322`
Period End Date	20151130
Filing Date	20160107
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	lndc-20151129.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 80 Cash Flow Statement 78

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$366.00K	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$382.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.24M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.13M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.97M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.97M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $366 and $382 at November 29, 2015 and May 31, 2015, respectively	`AccountsReceivableNetCurrent`	$50.28M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $366 and $382 at November 29, 2015 and May 31, 2015, respectively	`AccountsReceivableNetCurrent`	$46.48M	USD	Point-in-time
Inventories, net	`InventoryNet`	$25.03M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	27.03M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	26.99M	shares	Point-in-time
Inventories, net	`InventoryNet`	$28.86M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	26.99M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	27.03M	shares	Point-in-time
Deferred taxes	`DeferredTaxAssetsNetCurrent`	$2.06M	USD	Point-in-time
Deferred taxes	`DeferredTaxAssetsNetCurrent`	$2.11M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.46M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.01M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$93.20M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$95.19M	USD	Point-in-time
Investment in non-public company, fair value	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue`	$62.50M	USD	Point-in-time
Investment in non-public company, fair value	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue`	$61.50M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$95.87M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$84.47M	USD	Point-in-time
Goodwill, net	`Goodwill`	$49.62M	USD	Point-in-time
Goodwill, net	`Goodwill`	$49.62M	USD	Point-in-time
Trademarks/tradenames, net	`IndefiniteLivedTrademarks`	$48.43M	USD	Point-in-time
Trademarks/tradenames, net	`IndefiniteLivedTrademarks`	$48.43M	USD	Point-in-time
Customer relationships, net	`FiniteLivedCustomerListsNet`	$7.41M	USD	Point-in-time
Customer relationships, net	`FiniteLivedCustomerListsNet`	$7.83M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.42M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.08M	USD	Point-in-time
Total Assets	`Assets`	$361.11M	USD	Point-in-time
Total Assets	`Assets`	$346.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$36.92M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$35.01M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$1.23M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$527.00K	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$5.38M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$6.74M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$5.88M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$3.98M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$381.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$843.00K	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$13.53M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$8.35M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$56.16M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$62.62M	USD	Point-in-time
Long-term debt, less current portion	`LongTermDebtNoncurrent`	$34.17M	USD	Point-in-time
Long-term debt, less current portion	`LongTermDebtNoncurrent`	$34.69M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesNoncurrent`	$34.34M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesNoncurrent`	$35.46M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesCurrent`	$1.67M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesCurrent`	$1.69M	USD	Point-in-time
Total Liabilities	`Liabilities`	$126.36M	USD	Point-in-time
Total Liabilities	`Liabilities`	$134.43M	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized; 27,033,136 and 26,990,490 shares issued and outstanding at November 29, 2015 and May 31, 2015, respectively	`CommonStockValue`	$27.00K	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized; 27,033,136 and 26,990,490 shares issued and outstanding at November 29, 2015 and May 31, 2015, respectively	`CommonStockValue`	$27.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$135.20M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$133.31M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$89.92M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$85.10M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$225.15M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$218.43M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.68M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.52M	USD	Point-in-time
Total Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$226.67M	USD	Point-in-time
Total Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$220.11M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$361.11M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$346.46M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Product sales	`SalesRevenueGoodsNet`	$275.80M	USD	2 Qtrs
Product sales	`SalesRevenueGoodsNet`	$266.28M	USD	2 Qtrs
Product sales	`SalesRevenueGoodsNet`	$132.66M	USD	1 Quarter
Product sales	`SalesRevenueGoodsNet`	$140.44M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$123.18M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$240.55M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$236.43M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$117.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$29.85M	USD	2 Qtrs
Gross profit	`GrossProfit`	$17.27M	USD	1 Quarter
Gross profit	`GrossProfit`	$35.24M	USD	2 Qtrs
Gross profit	`GrossProfit`	$15.67M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.64M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.62M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.82M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.52M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$12.81M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$24.98M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$18.81M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$9.95M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$11.77M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$14.46M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$28.50M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$22.43M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$6.75M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$3.89M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$7.43M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$2.81M	USD	1 Quarter
Dividend income	`InvestmentIncomeDividend`	$825.00K	USD	2 Qtrs
Dividend income	`InvestmentIncomeDividend`	$321.00K	USD	1 Quarter
Dividend income	`InvestmentIncomeDividend`	$602.00K	USD	2 Qtrs
Dividend income	`InvestmentIncomeDividend`	$413.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$16.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$184.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$47.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$91.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$855.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$439.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$472.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$941.00K	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$1.00M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$1.40M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$200.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$1.20M	USD	1 Quarter
Net income before taxes	`OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent`	$5.03M	USD	1 Quarter
Net income before taxes	`OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent`	$3.00M	USD	1 Quarter
Net income before taxes	`OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent`	$7.68M	USD	2 Qtrs
Net income before taxes	`OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent`	$8.76M	USD	2 Qtrs
Income tax expense	`OtherComprehensiveIncomeLossTaxPortionAttributableToParent1`	$3.09M	USD	2 Qtrs
Income tax expense	`OtherComprehensiveIncomeLossTaxPortionAttributableToParent1`	$1.78M	USD	1 Quarter
Income tax expense	`OtherComprehensiveIncomeLossTaxPortionAttributableToParent1`	$1.07M	USD	1 Quarter
Income tax expense	`OtherComprehensiveIncomeLossTaxPortionAttributableToParent1`	$2.76M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$3.25M	USD	1 Quarter
Consolidated net income	`ProfitLoss`	$1.93M	USD	1 Quarter
Consolidated net income	`ProfitLoss`	$4.92M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$5.67M	USD	2 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$96.00K	USD	2 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$95.00K	USD	2 Qtrs
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$24.00K	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$60.00K	USD	1 Quarter
Net income and comprehensive income applicable to common stockholders	`ComprehensiveIncomeNetOfTax`	$3.22M	USD	1 Quarter
Net income and comprehensive income applicable to common stockholders	`ComprehensiveIncomeNetOfTax`	$1.87M	USD	1 Quarter
Net income and comprehensive income applicable to common stockholders	`ComprehensiveIncomeNetOfTax`	$4.82M	USD	2 Qtrs
Net income and comprehensive income applicable to common stockholders	`ComprehensiveIncomeNetOfTax`	$5.58M	USD	2 Qtrs
Basic net income per share (in dollars per share)	`EarningsPerShareBasic`	$0.07	USD	1 Quarter
Basic net income per share (in dollars per share)	`EarningsPerShareBasic`	$0.18	USD	2 Qtrs
Basic net income per share (in dollars per share)	`EarningsPerShareBasic`	$0.21	USD	2 Qtrs
Basic net income per share (in dollars per share)	`EarningsPerShareBasic`	$0.12	USD	1 Quarter
Diluted net income per share (in dollars per share)	`EarningsPerShareDiluted`	$0.20	USD	2 Qtrs
Diluted net income per share (in dollars per share)	`EarningsPerShareDiluted`	$0.07	USD	1 Quarter
Diluted net income per share (in dollars per share)	`EarningsPerShareDiluted`	$0.12	USD	1 Quarter
Diluted net income per share (in dollars per share)	`EarningsPerShareDiluted`	$0.18	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	26.86M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.01M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.02M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	26.85M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.42M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.42M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.29M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.31M	shares	1 Quarter

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Consolidated net income	`ProfitLoss`	$3.25M	USD	1 Quarter
Consolidated net income	`ProfitLoss`	$1.93M	USD	1 Quarter
Consolidated net income	`ProfitLoss`	$4.92M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$5.67M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.83M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.34M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.13M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.34M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$748.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.70M	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$90.00K	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$36.00K	USD	2 Qtrs
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$1.42M	USD	2 Qtrs
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$1.17M	USD	2 Qtrs
Change in investment in non-public company, fair value	`FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss`	$1.00M	USD	2 Qtrs
Change in investment in non-public company, fair value	`FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss`	$1.40M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInReceivables`	$7.57M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInReceivables`	$3.80M	USD	2 Qtrs
Inventories, net	`IncreaseDecreaseInInventories`	$5.71M	USD	2 Qtrs
Inventories, net	`IncreaseDecreaseInInventories`	$3.83M	USD	2 Qtrs
Issuance of notes and advances receivable	`IncreaseDecreaseInNotesReceivables`	$621.00K	USD	2 Qtrs
Issuance of notes and advances receivable	`IncreaseDecreaseInNotesReceivables`	$2.46M	USD	2 Qtrs
Collection of notes and advances receivable	`ProceedsFromCollectionOfNotesReceivable`	$249.00K	USD	2 Qtrs
Collection of notes and advances receivable	`ProceedsFromCollectionOfNotesReceivable`	$363.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$2.09M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$-2.06M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.91M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$7.40M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-702.00K	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	-	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$877.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.36M	USD	2 Qtrs
Other accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.87M	USD	2 Qtrs
Other accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-303.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-1.04M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-462.00K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$3.35M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$2.19M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.13M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.20M	USD	2 Qtrs
Deposit on capital lease	`DepositOnCapitalLease`	$850.00K	USD	2 Qtrs
Deposit on capital lease	`DepositOnCapitalLease`	-	USD	2 Qtrs
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$91.00K	USD	2 Qtrs
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Investment in non-public company, fair value	`PaymentsToAcquireInvestments`	-	USD	2 Qtrs
Investment in non-public company, fair value	`PaymentsToAcquireInvestments`	$18.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-15.96M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-25.14M	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$108.00K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$100.00K	USD	2 Qtrs
Taxes paid by Company for stock swaps and RSUs	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$12.00K	USD	2 Qtrs
Taxes paid by Company for stock swaps and RSUs	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$36.00K	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$90.00K	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$11.19M	USD	2 Qtrs
Proceeds from long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$9.97M	USD	2 Qtrs
Payments on long-term debt	`RepaymentsOfLongTermDebt`	$3.34M	USD	2 Qtrs
Payments on long-term debt	`RepaymentsOfLongTermDebt`	$4.28M	USD	2 Qtrs
Proceeds from lines of credit	`ProceedsFromLinesOfCredit`	$25.12M	USD	2 Qtrs
Proceeds from lines of credit	`ProceedsFromLinesOfCredit`	$10.50M	USD	2 Qtrs
Payments on lines of credit	`RepaymentsOfLinesOfCredit`	$20.12M	USD	2 Qtrs
Payments on lines of credit	`RepaymentsOfLinesOfCredit`	$10.50M	USD	2 Qtrs
Change in other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$26.00K	USD	2 Qtrs
Change in other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$269.00K	USD	2 Qtrs
Payments to non-controlling interest holders	`PaymentsToMinorityShareholders`	$196.00K	USD	2 Qtrs
Payments to non-controlling interest holders	`PaymentsToMinorityShareholders`	$248.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$5.62M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$12.51M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-9.27M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-8.15M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$14.24M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$14.13M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.97M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.97M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$14.24M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$14.13M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.97M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.97M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.